Ovotransferrin Inhibits TNF-α Induced Inflammatory Response in Gastric Epithelial Cells via MAPK and NF-κB Pathway

Yan Huang1,2,3, Shuping Chen1,2,3, Yao Yao1,2,3

  • 1Jiangxi Key Laboratory of Natural Products and Functional Food, Jiangxi Agricultural University, Nanchang 330045, China.

Insights

Ovotransferrin (OVT) effectively reduces gastric inflammation by inhibiting key inflammatory cytokines like IL-8, IL-6, and TNF-α. This natural protein works by suppressing the MAPK and NF-κB signaling pathways, showing potential for treating gastric inflammation.

Area of Science:

  • Gastroenterology and Immunology
  • Biochemistry and Molecular Biology

Background:

  • Ovotransferrin (OVT) possesses known anti-inflammatory properties.
  • The specific mechanisms of OVT's action on gastric inflammation remain largely uncharacterized.

Purpose of the Study:

  • To investigate the anti-inflammatory effects of Ovotransferrin (OVT) on gastric epithelial cells (GES-1) stimulated with tumor necrosis factor-α (TNF-α).
  • To elucidate the underlying molecular mechanisms, particularly the involvement of MAPK and NF-κB signaling pathways.

Main Methods:

  • Enzyme-linked immunosorbent assay (ELISA) for quantifying inflammatory cytokines.
  • RNA sequencing to identify affected cellular pathways.
  • Western blotting and pathway inhibitors to validate molecular mechanisms.

Main Results:

  • Ovotransferrin (OVT) demonstrated no toxicity to GES-1 cells at tested concentrations (50-400 μg/mL).
  • OVT significantly reduced the secretion of interleukin-8 (IL-8), IL-6, and TNF-α.
  • RNA sequencing and subsequent validation confirmed OVT's inhibition of mitogen-activated protein kinase (MAPK) and nuclear factor kappa-light-chain enhancer of activated B cell (NF-κB) pathways.

Conclusions:

  • Ovotransferrin (OVT) exhibits significant anti-inflammatory effects in gastric epithelial cells.
  • OVT exerts its protective effects by modulating the MAPK and NF-κB signaling cascades.
  • OVT is a promising natural protein therapeutic candidate for managing gastric inflammation.

Related Concept Videos

NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
7.5K
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF01:24

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
173
Gastritis-II: Pathophysiology01:17

Gastritis-II: Pathophysiology

Gastritis is marked by disruption of the mucosal barrier that usually protects the stomach tissue from digestive juices and manifests in acute and chronic forms.
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
375
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.4K
Inflammatory Response01:28

Inflammatory Response

An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
2.1K
T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
1.1K